In episode 320, Mike and James PREMIUM out yet again and talk about 3 new diabetes publications that our listeners have asked us about.
1) LEADER Study
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2) Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
3) Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care